BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

972 related articles for article (PubMed ID: 26640149)

  • 21. PUMA promotes apoptosis of hematopoietic progenitors driving leukemic progression in a mouse model of myelodysplasia.
    Guirguis AA; Slape CI; Failla LM; Saw J; Tremblay CS; Powell DR; Rossello F; Wei A; Strasser A; Curtis DJ
    Cell Death Differ; 2016 Jun; 23(6):1049-59. PubMed ID: 26742432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of MdmX as a therapeutic target for reactivating p53 in tumors.
    Garcia D; Warr MR; Martins CP; Brown Swigart L; Passegué E; Evan GI
    Genes Dev; 2011 Aug; 25(16):1746-57. PubMed ID: 21852537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of p53-dependent apoptosis leads to UV radiation hypersensitivity, enhanced immunosuppression and cellular senescence.
    Tavana O; Benjamin CL; Puebla-Osorio N; Sang M; Ullrich SE; Ananthaswamy HN; Zhu C
    Cell Cycle; 2010 Aug; 9(16):3328-36. PubMed ID: 20703098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis.
    Vecchio E; Golino G; Pisano A; Albano F; Falcone C; Ceglia S; Iaccino E; Mimmi S; Fiume G; Giurato G; Britti D; Scala G; Quinto I
    Cell Death Dis; 2019 Apr; 10(4):320. PubMed ID: 30975981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.
    Shreeram S; Hee WK; Demidov ON; Kek C; Yamaguchi H; Fornace AJ; Anderson CW; Appella E; Bulavin DV
    J Exp Med; 2006 Dec; 203(13):2793-9. PubMed ID: 17158963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death.
    Michalak EM; Vandenberg CJ; Delbridge AR; Wu L; Scott CL; Adams JM; Strasser A
    Genes Dev; 2010 Aug; 24(15):1608-13. PubMed ID: 20679396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.
    Hemann MT; Bric A; Teruya-Feldstein J; Herbst A; Nilsson JA; Cordon-Cardo C; Cleveland JL; Tansey WP; Lowe SW
    Nature; 2005 Aug; 436(7052):807-11. PubMed ID: 16094360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim.
    Happo L; Cragg MS; Phipson B; Haga JM; Jansen ES; Herold MJ; Dewson G; Michalak EM; Vandenberg CJ; Smyth GK; Strasser A; Cory S; Scott CL
    Blood; 2010 Dec; 116(24):5256-67. PubMed ID: 20829369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis.
    Post SM; Quintás-Cardama A; Terzian T; Smith C; Eischen CM; Lozano G
    Oncogene; 2010 Mar; 29(9):1260-9. PubMed ID: 19935700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of tumorigenesis by the p53 target PUMA.
    Hemann MT; Zilfou JT; Zhao Z; Burgess DJ; Hannon GJ; Lowe SW
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9333-8. PubMed ID: 15192153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma.
    Hunter JE; Butterworth JA; Zhao B; Sellier H; Campbell KJ; Thomas HD; Bacon CM; Cockell SJ; Gewurz BE; Perkins ND
    Oncogene; 2016 Jun; 35(26):3476-84. PubMed ID: 26522720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teratogen-induced activation of p53 in early postimplantation mouse embryos.
    Hosako H; Little SA; Barrier M; Mirkes PE
    Toxicol Sci; 2007 Jan; 95(1):257-69. PubMed ID: 17068108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG.
    Thakur VS; Ruhul Amin AR; Paul RK; Gupta K; Hastak K; Agarwal MK; Jackson MW; Wald DN; Mukhtar H; Agarwal ML
    Cancer Lett; 2010 Oct; 296(2):225-32. PubMed ID: 20444544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
    Nilsson JA; Keller UB; Baudino TA; Yang C; Norton S; Old JA; Nilsson LM; Neale G; Kramer DL; Porter CW; Cleveland JL
    Cancer Cell; 2005 May; 7(5):433-44. PubMed ID: 15894264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultraviolet radiation triggers apoptosis of fibroblasts and skin keratinocytes mainly via the BH3-only protein Noxa.
    Naik E; Michalak EM; Villunger A; Adams JM; Strasser A
    J Cell Biol; 2007 Feb; 176(4):415-24. PubMed ID: 17283183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the translocation partner in protection against AID-dependent chromosomal translocations.
    Jankovic M; Robbiani DF; Dorsett Y; Eisenreich T; Xu Y; Tarakhovsky A; Nussenzweig A; Nussenzweig MC
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):187-92. PubMed ID: 19966290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma.
    Newbold A; Salmon JM; Martin BP; Stanley K; Johnstone RW
    Oncogene; 2014 Nov; 33(47):5415-23. PubMed ID: 24292681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
    Eischen CM; Weber JD; Roussel MF; Sherr CJ; Cleveland JL
    Genes Dev; 1999 Oct; 13(20):2658-69. PubMed ID: 10541552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic genetic dissection of p14ARF-mediated mitochondrial cell death signaling reveals a key role for p21CDKN1 and the BH3-only protein Puma/bbc3.
    Hemmati PG; Müer A; Gillissen B; Overkamp T; Milojkovic A; Wendt J; Dörken B; Daniel PT
    J Mol Med (Berl); 2010 Jun; 88(6):609-22. PubMed ID: 20419447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.